These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10080117)

  • 21. Retention of topical liposomal formulations on the cornea.
    McCalden TA; Levy M
    Experientia; 1990 Jul; 46(7):713-5. PubMed ID: 2373198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preliminary study of corneal penetration of 125I-labelled idoxuridine liposome.
    Dharma SK; Fishman PH; Peyman GA
    Acta Ophthalmol (Copenh); 1986 Jun; 64(3):298-301. PubMed ID: 3751519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic analysis of the interaction between liposomes and the complement system in rat serum: re-evaluation of size-dependency.
    Yamada M; Harashima H; Kiwada H
    Biol Pharm Bull; 1998 Sep; 21(9):964-8. PubMed ID: 9781848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabrication and characterization of contact lenses bearing surface-immobilized layers of intact liposomes.
    Danion A; Brochu H; Martin Y; Vermette P
    J Biomed Mater Res A; 2007 Jul; 82(1):41-51. PubMed ID: 17265438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomes in topical drug delivery.
    Schaeffer HE; Krohn DL
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):220-7. PubMed ID: 7056633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of fluorescein to the anterior chamber using the corneal collagen shield.
    Reidy JJ; Limberg M; Kaufman HE
    Ophthalmology; 1990 Sep; 97(9):1201-3. PubMed ID: 2234854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal epithelial permeability after excimer laser photorefractive keratectomy.
    Kim KS; Lee JH; Edelhauser HF
    J Cataract Refract Surg; 1996; 22(1):44-50. PubMed ID: 8656361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication.
    Hathout RM; Gad HA; Abdel-Hafez SM; Nasser N; Khalil N; Ateyya T; Amr A; Yasser N; Nasr S; Metwally AA
    Int J Pharm; 2019 Feb; 556():192-199. PubMed ID: 30553005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of liposome encapsulation of a fluorescent dye on its uptake by the lymphatics of the rat.
    Parker RJ; Sieber SM; Weinstein JN
    Pharmacology; 1981; 23(3):128-36. PubMed ID: 7280007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precorneal factors influencing the ocular distribution of topically applied liposomal inulin.
    Lee VH; Takemoto KA; Iimoto DS
    Curr Eye Res; 1984 Apr; 3(4):585-91. PubMed ID: 6713957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
    Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
    Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of reduced tear drainage on corneal and aqueous concentrations of topically applied fluorescein.
    Lindén C; Alm A
    Acta Ophthalmol (Copenh); 1990 Dec; 68(6):633-8. PubMed ID: 2080690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescent Imaging Analysis for Distribution of Fluorescent Dye Labeled- or Encapsulated-Liposome in Monocrotaline-Induced Pulmonary Hypertension Model Rat.
    Muraki Y; Yamasaki M; Takeuchi H; Tohyama K; Sano N; Matsuo T
    Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):270-276. PubMed ID: 29311495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic toxicology and laser safety of laser targeted angiography with heat sensitive liposomes.
    Asrani S; D'Anna S; Alkan-Onyuksel H; Wang W; Goodman D; Zeimer R
    J Ocul Pharmacol Ther; 1995; 11(4):575-84. PubMed ID: 8574821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Factors of elimination of liposome-encapsulated drug model substances after intravenous administration].
    Kibat P; Stricker H
    Arzneimittelforschung; 1988 Oct; 38(10):1472-8. PubMed ID: 3196388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum.
    Silvander M; Johnsson M; Edwards K
    Chem Phys Lipids; 1998 Dec; 97(1):15-26. PubMed ID: 10081146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical liposome delivery of molecules to hair follicles in mice.
    Li L; Hoffman RM
    J Dermatol Sci; 1997 Feb; 14(2):101-8. PubMed ID: 9039973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety evaluation of nanoliposomes containing cyclosporine a after ocular administration.
    Mosallaei N; Banaee T; Farzadnia M; Abedini E; Ashraf H; Malaekeh-Nikouei B
    Curr Eye Res; 2012 Jun; 37(6):453-6. PubMed ID: 22577761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.
    Babizhayev MA
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1071-89. PubMed ID: 18777243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.